Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 2/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10492340 | 0.85 | CYP11B1 (0.46) | CHRNA7CYP1A2CYP2D6CYP2A6HRH4 | |
| SCHEMBL724866 | 0.82 | CHRNA7 (0.74) | CHRNA7CYP1A2CYP2D6CYP2A6HRH4 | |
| SCHEMBL29485692 | 0.82 | CHRNA7 (0.74) | CHRNA7CYP1A2CYP2D6CYP2A6HRH4 | |
| SCHEMBL10492284 | 0.81 | CHRNA7 (0.57) | CHRNA7CYP1A2CYP2D6CYP2A6HRH4 | |
| SCHEMBL1041978 | 0.81 | CYP1A2 (0.70) | CYP1A2CYP2D6TDP1 | |
| SCHEMBL3170078 | 0.79 | CHRNA7 (0.44) | CHRNA7CYP1A2CYP2D6CYP2A6TDP1 | |
| SCHEMBL3154751 | 0.78 | CYP2D6 (0.51) | CHRNA7CYP1A2CYP2D6CYP2A6HRH4 | |
| SCHEMBL28057954 | 0.76 | CHRNA7 (0.52) | CHRNA7CYP1A2CYP2D6CYP2A6HRH4 | |
| SCHEMBL10452373 | 0.76 | CHRNA7 (0.65) | CHRNA7CYP1A2CYP2D6CYP2A6HRH4 | |
| SCHEMBL8700016 | 0.76 | CYP1A2 (0.66) | CHRNA7CYP1A2CYP2D6CYP2A6HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6979693-B2 | Pyrazole derivatives-p38 MAP kinase inhibitors | SYNTEX (U.S.A.) LLC (US) | 2005-12-27 | — | — | US | disclosed |
| CN-1147476-C | Pyrazole derivatives as P-38 MAP kinase inhibitors | - | 2004-04-28 | — | — | CN | disclosed |
| US-6444696-B1 | 1-ARYL OR HETEROARYL SUBSTITUTED 5-AMINO-4 CARBONYLPYRAZOLE DERIVATIVES; ANTIINFLAMMATORY AGENTS | SYNTEX (U.S.A.) LLC | 2002-09-03 | — | — | US | disclosed |
| US-6376527-B1 | ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASES | SYNTEX (U.S.A.) LLC | 2002-04-23 | — | — | US | disclosed |
| US-6316466-B1 | Pyrazole derivatives P-38 MAP kinase inhibitors | SYNTEX (U.S.A.) LLC | 2001-11-13 | — | — | US | disclosed |
| CN-1300282-A | Pyrazole derivatives as P-38 MAP kinase inhibitors | HOFFMANN LA ROCHE (CH) | 2001-06-20 | — | — | CN | disclosed |